Walleye Capital
KRTX

Walleye Capital’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Walleye Capital’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-6,605
Closed -$1.26M – 4496
2022
Q4 		$1.3M Buy
+6,605
New +$1.42M 0.02% 834
2022
Q2 		– Sell
-30,406
Closed -$3.85M – 2786
2022
Q1 		$3.85M Buy
+30,406
New +$3.42M 0.1% 210

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Walleye Capital's KRTX Position: Q1 2023 in Review

Walleye Capital sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2023, closing a stake of 6,605 shares — an estimated $1.26M sold.

Walleye Capital first reported a position in KRTX in Q1 2022 and held it in 2 quarters. The position peaked at $3.85M in Q1 2022. 246 funds tracked by Wall St. Rank hold KRTX as of Q1 2023.

  • Walleye Capital reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Walleye Capital sold 6,605 Karuna Therapeutics, Inc. Common Stock shares in Q1 2023, an estimated $1.26M.
  • Walleye Capital first reported a position in Karuna Therapeutics, Inc. Common Stock in Q1 2022 and held it in 2 quarters.
  • Walleye Capital's Karuna Therapeutics, Inc. Common Stock position peaked at $3.85M in Q1 2022.
  • 246 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2023.

Based on Walleye Capital's 13F filing for Q1 2023, filed 15 May 2023.